FIELD: pharmacology.
SUBSTANCE: invention relates to a method for preparation of a compound of the formula
and intermediates used to implement the method, as well as a method for pregabalin preparation.
EFFECT: method can be implemented on a commercial scale using readily available, safe raw materials and reagents, and without the need for difficult separations.
20 cl, 8 tbl, 41 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING (S)-3-AMINOMETHYL-5-METHYLHEXANOIC ACID (PREGABALIN) | 2013 |
|
RU2544859C1 |
NOVEL COMPOUNDS POSSESSING ANTI-INFLAMMATORY ACTIVITY AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 2001 |
|
RU2288225C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679609C1 |
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2686117C1 |
PYRAZINONE DERIVATIVES AND USE THEREOF IN TREATMENT OF LUNG DISEASES | 2008 |
|
RU2479580C2 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696270C1 |
Authors
Dates
2017-08-15—Published
2014-03-25—Filed